The agency also affirmed the following ratings on HSHS’ bonds, including:
- “AA-” long-term rating on its series 2017A bonds
- “AA-” long-term rating its series 2016 bonds
- “AA-” long-term rating on its series 2012C bonds
- “AA-” long-term rating on its series 2012B bonds
- “AA-” underlying rating on its series 2007A
- “AA-” underlying rating on its series 2007C bonds
- “AA-/A-1+” dual rating on its series 2012H and 2012I bonds
- “AA-/A-1+” dual rating and “AA-” rating on its series 2012G bonds.
“The ‘AA-‘ rating continues to reflect our view of HSHS leadership’s successful implementation of a strategic plan, which has helped improve the system’s operations while maintaining its strong balance sheet,” said S&P analyst Brian Williamson.
The outlook is stable, reflecting S&P’s opinion that HSHS’ senior management will be able to achieve its goal of a 2 percent operating margin.
More articles on healthcare finance:
Nationwide, others partner to donate $400k to Nationwide Children’s Hospital
Henry Ford Health System records landmark year for gift revenue
Report: NJ hospitals contributed nearly $22.7B to state economy in 2015
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
